This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Operator
Good morning and welcome to Edgewell Personal Care first quarter 2024 earnings call. All participants will be in listen only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Chris Goff. Please go ahead.
Chris Goff
Good morning, everyone, and thank you for joining us this morning for Edgewell's first quarter fiscal year 2024 earnings call. With me this morning are Rod Little, our President and Chief Executive Officer, and Dan Sullivan, our Chief Financial Officer. Rod will kick off the call then hand it over to Dan to discuss our results and full year fiscal 2024 outlook before we transition to Q&A. This call is being recorded and will be available for replay via our website, www.edgewell.com. During the call, we may make statements about our expectations for future plans and performance. This might include future sales, earnings, advertising and promotional spending, product launches, savings and costs related to restructuring and repositioning actions, acquisitions and integrations, changes to our working capital metrics, currency fluctuations, commodity costs, category value, future plans for return of capital to shareholders, and more. Any such statements are forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, which reflect our current views with respect to future events, plans, or prospects. These statements are based on assumptions and are subject to various risks and uncertainties, including those described under the caption risk factors in our annual report on Form 10-K for the year ended September 30, 2023, as may be amended in our quarterly reports on Form 10-Q, which is on file with the SEC. These risks may cause our actual results to be materially different from those expressed or implied by our forward-looking statements. We do not assume any obligation to update or revise any of these forward-looking statements to reflect new events or circumstances, except as required by law. During this call, we will refer to certain non-GAAP financial measures. These non-GAAP measures are not prepared in accordance with generally accepted accounting principles. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures is shown in our press release issued earlier today, which is available at the investor relations section of our website. This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. However, management believes these non-GAAP measures provide investors with valuable information on the underlying trends of our business. With that, I'd like to turn the call over to Rob.
Rod Little
Thank you, Chris. Good morning, everyone, and thanks for joining us on our fiscal 24 first quarter earnings call. We had a good start to the year with 3% organic net sales growth, largely driven by strong performance in international markets, where mostly healthier categories and improved in-market execution drove growth. The growth was underpinned by both price and volume gains. Notably, we saw meaningful organic growth and market share gains in both Japan and Germany, reflecting both good consumer response to our brands and also strong wholesaler and retailer support. I am very excited about the results we are seeing in our international markets as we continue to strengthen our capabilities and streamline our leadership structure across the business. A year ago, we brought the markets closer to our global center, with all non-North American markets directly reporting to me and Dan. We also made significant changes in leadership across Europe, Japan, and China, which collectively represent almost two-thirds of our international business. And we've continued to push decision-making and accountability to the local teams, all of which has contributed to a more robust organic growth profile. In North America, despite some transitory dynamics that contributed to year-over-year organic net sales declines, most notably in femcare, our consumption and resulting market share results were solid and largely in line with trend. Across our markets, the consumer remains resilient, our categories remain relatively healthy, and as we move into our bigger spring and summer selling seasons, We believe we are well positioned with notable innovation in Suncare, our brand replatforming in Femcare, and the Billy launch into new body categories all in front of us. Adjusted gross margin expanded year over year ahead of our expectations, driven by our ability to accelerate productivity savings and realize gains from improved price and revenue management. We increased investment in our brands in the quarters. remained disciplined on G&A costs, and delivered adjusted EBITDA and EPS ahead of our expectations. With this good start to the year and with strong fundamentals in place, we have increased confidence in our ability to deliver our outlook for both top and bottom line. The first quarter was a good example of the business model we have built and ultimately our path for continued success. Solid top line growth with good market share outcomes, accelerated gross margin accretion, incremental commercial investment in support of priority brands and markets, and a healthy, sustainable profit profile. Importantly, our portfolio of leading brands continues to be top of mind for consumers across the globe, regardless of their preferred channel, in-store or online. In our shaving business, we are seeing the clear advantages of our manufacturing technology and improved brand building and digital capabilities. with compelling innovation and stronger retailer partnerships globally, private brands, market share gains, and the successful retail expansion of the Billy brand here in the United States and in Canada, all demonstrating clear proof points of a healthier Shea portfolio. In Suncare, the mid-single-digit organic growth in the quarter was in line with expectations, and we saw good execution from concept to shelf across our leading portfolio of trusted brands. Our end-to-end capabilities of product formulation, regulatory, quality control, internal manufacturing, and direct store delivery to shelf are all points of competitive advantage that contribute to our broader success. Our grooming portfolio of well-crafted brands continues to resonate with consumers and will soon be augmented by the disruptive force of the Billy brand as we begin to execute our retail pilot and the initial launch of the brand's offering, Embody, beginning today. And finally, in Femcare, we believe that we've now cycled through the supply chain and demand imbalances that have plagued the category over the last 18 months and make year-over-year comparisons challenging. I'm personally bullish about the opportunity that our new master brand strategy offers as we re-platform our pads and liners business under the Carefree brand with a unique consumer positioning, and emotive campaign that I expect will resonate well with our target consumers. Our brands are healthier and, once again this year, better represented across all channels of distribution than at any point since we began as an independent company in 2015. The initial read on distribution outcomes for 2024 is encouraging, all of which underpins our durable, sustainable, top-line growth profile this fiscal year and beyond. Operationally, we remained disciplined in the face of continued, though easing, inflationary headwinds. We generated almost 600 basis points of combined gross margin benefits from productivity and efficiency initiatives, as well as price and revenue management execution. Our teams did a terrific job in the quarter of driving operational excellence across the supply chain, while further realizing the benefits of our focus on unit economics and sound revenue and promotion management. And importantly, as planned, we increased investment in support of our brands with spend centered around digital activation ahead of the compelling innovation that will come to market later this quarter. So to wrap up, the results this quarter and our outlook for the full year illustrate the progress we've made since outlining our long-term vision and growth goals in 2020. And importantly, demonstrate that our strategy is working. As we move past peak inflationary pressures that we have contended with for the past two years, we remain confident in our financial model, which calls for organic net sales growth, gross margin accretion, G&A leverage, and strong free cash flow generation. Simply put, our business is better with a stronger portfolio of brands and a demonstrated ability to successfully execute against each of our key strategic priorities. This gives us confidence that we will deliver significant value creation for our shareholders. And now I'd like to ask Dan to take you through our first quarter results and discuss our outlook for fiscal 24. Dan?
Chris
Thank you, Rod. Good morning, everyone. As Rod mentioned, operational and commercial execution in the quarter was strong, particularly in our international markets, which helped drive solid top-line growth, good market share results, and notable gross margin accretion. all of which enabled better than expected earnings and cash generation for the quarter, while setting us up well to deliver full-year results in line with our previous outlook. For the quarter, organic net sales grew 3.1%, largely driven by higher pricing. International organic growth was just over 16%, underpinned by both price and volume gains. In the quarter, the consumer remained resilient, with our categories in aggregate continuing to grow, and signs of structural recovery in key international markets like Japan and Germany. Aggregate consumption across our U.S. segments increased 2.2% in the quarter, below 52-week trends, as gains from pricing eased compared to a year ago. Importantly, volume consumption remained strong in both women's shave and grooming, where we gained and held volume share, respectively. Operationally, our teams continue to execute, The supply chain organization further improved service levels and unit fill rates while realizing better than expected productivity savings. And our commercial teams drove strong gains from both price and promotion management. In total, these efforts combined to provide almost 600 basis points of gross margin tailwinds in the quarter, which nearly offset the transitory unfavorable effect of lower manufacturing absorption and the negative effect of heightened unit cost inflation trapped in inventory. both of which we previewed last quarter. Despite these significant one-time headwinds, we delivered 30 basis points of adjusted gross margin accretion, adjusted EPS of 24 cents per share, and adjusted EBITDA of $57.2 million, all of which were above our expectations. Now, let me turn to the detailed results for the quarter. As mentioned, organic net sales increased 3.1%, driven by strong performance across international markets, all of which grew year over year. The strong international performance was a result of nearly double-digit volume growth, coupled with mid-single-digit price-related gains. Performance in Japan was a highlight, as a return to healthy category consumption was met with strong price execution and a favorable pull-forward of purchases ahead of the New Year holiday. Organic sales in North America were down 4.9%, more than half of which was attributable to declines in femcare, as we cycled double-digit organic growth last year. North America volumes were down just over 6% while pricing delivered over one point of growth. Wet shave organic net sales were up 8.1% with growth across men's and women's systems, disposables, and preps. International wet shave growth stood out in the quarter at 18% as a result of improved market conditions, strong in-market brand activation, higher pricing, and the aforementioned replenishment phasing benefits in Japan. In the quarter, we saw meaningful market share gains in Japan, Germany, and Canada. Wet shave organic sales in North America declined 2%, with declines in both disposables and preps more than offsetting a strong quarter for men's systems. In the U.S. razors and blades category, consumption was flat in the quarter, and our market share increased 10 basis points. Driven by share gains in branded women's systems, as Billy continued to scale at retail while also growing in newly activated online channels. In the quarter, the brand reached a 14 share at Walmart and a 7 share on Amazon, and in the most recent scanner data is now the number three brand in the set at Target and CVS. Despite the heightened competitive environment within the women's category, our branded volume share gains of 210 basis points were above recent trends. Men's systems and disposables market shares were essentially flat in the course. Sun and skin care organic net sales increased about 1%, as mid-single-digit growth in sun care was partially offset by declines in North America grooming and skin. North America sun care growth was over 5%, driven by higher volumes. International sun care sales increased just over 5% as well, despite cycling almost 70% growth last year, driven primarily by higher pricing. In the U.S., the sun care category was up approximately 8%, and our share was essentially flat. Grooming organic net sales decreased 2.6%, as bulldog growth in Europe was more than offset by declines in Cremo in the U.S., as we cycled certain MPD launches a year ago. Wet ones organic net sales declined 1.3%, and our share grew to approximately 77%. Femcare organic net sales were down 11.2% for the quarter, primarily reflecting lower volumes. Consumption in the category was up 1.5%, or half the rate of the previous 52 weeks, and our share of the market declined one point. In the quarter, we cycled competitive out of stocks a year ago and felt the impact of retailer inventory buy-downs, in part a result of the carefree master brand launch happening later in the spring. However, increased promotional intensity in the tampons category as competition returned to shelf, and the magnitude of the retailer destocking caused a higher than expected drag on organic sales and share performance in the quarter. Now, moving down the P&L. Gross margin rate on an adjusted basis increased 30 basis points, inclusive of 70 basis points of favorable currency. Approximately 380 basis points of productivity savings, and 210 basis points of price gains partially offset 520 basis points of transitory cost headwinds related to unfavorable absorption and heightened unit cost inflation trapped in inventory. Core gross inflation pressures of about 70 basis points and 40 basis points of negative mix and other items. A&P expenses were 9.9% of net sales, 10 basis points higher than the prior year. Adjusted SG&A increased 110 basis points in rate of sale versus last year as higher incentive compensation and people-related costs and the impact of unfavorable currency movements were only partly offset by savings realized from ongoing operational efficiency programs and sales leverage. Adjusted operating income was $35.7 million compared to $37.3 million last year, a decrease of approximately 4%. GAAP diluted net earnings per share were $0.09 compared to $0.24 in the first quarter of fiscal 23, and adjusted earnings per share were $0.24 compared to $0.32 in the prior year period. Currency movements had no material impact on adjusted earnings per share as currency benefits within operating profit were offset by lower hedge gains within other income and expense. Adjusted EBITDA was $57.2 million compared to $64.5 million in the prior year. Net cash used from operating activities for the quarter was $72.9 million, compared to $86.3 million in the prior year period. We ended the quarter with $214 million in cash on hand, access to the $207 million undrawn portion of our credit facility, and a net debt leverage ratio of 3.8 times. In the quarter, share repurchases total $15 million and we continued our quarterly dividend payout and declared another cash dividend of 15 cents per share for the first quarter. In total, we returned nearly $23 million to shareholders during the quarter. Now, turning to our outlook for fiscal 2024. As Rod mentioned earlier, with a good start to the fiscal year and strong fundamentals in place, we have increased confidence in our ability to meet our previously provided outlook. which reflects sustainable top-line growth, gross margin accretion, and double-digit constant currency adjusted EPS growth. The macro environment remains challenging with an uncertain geopolitical and economic backdrop, potential risks from further supply chain disruptions, and a lack of clarity around the durability of the consumer resiliency that we have seen thus far. And while FX remains volatile, our assumption for currency impacts to the full fiscal year is unchanged from our prior outlook. For the fiscal year, we still anticipate organic net sales growth in the 2% to 4% range. Our outlook for gross margin accretion is unchanged as we continue to anticipate an increase of approximately 80 basis points or 100 basis points at constant currency. There is no change to our full-year view for the elements that underpin our gross margin profile, including inflationary headwinds, productivity savings, pricing, and FX. Adjusted EBITDA is still expected to be in the range of $340 to $352 million. Adjusted EPS is still expected to be in the range of $2.65 to $2.85, inclusive of approximately 20 cents per share of currency headwinds. In terms of phasing, we continue to expect similar organic sales growth rates between half one and half two, and we now expect 35% of our full-year EPS in half one, and 65% in half too. For more information related to our fiscal 2024 outlook, I would refer you to the press release that we issued earlier this morning. And now I'd like to return the call to the operator for the Q&A session.
Operator
We will now begin the Q&A. To ask a question, you may press star then one on your telephone keypad. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star then 2. At this time, we will pause momentarily to assemble our roster. The first question is from Nick Modi with RBC Capital Markets. Please go ahead.
Nick
Thanks. Good morning, everyone. Just a quick clarification, Dan, if you don't mind. Just obviously a pretty good result on earnings relative to kind of where I think most people were and you held the guidance. Is that just because of the pull forward in Japan? I just want to make sure I just understand exactly what's going on just from a cadence perspective. And then the broader question is just, you know, obviously international, 50% of your business, you know, you have a lot of change. you know, what inning are we in in terms of like the full foundation being set from some of your new operators in those markets and the new reporting structure, just to understand kind of how much more progress you can actually make in that market?
Chris
Hey, good morning, Nick. Thanks for the question. I'll take them in reverse order. I'll start with international because you're right. We've been on this journey now for a little over a year. Rod alluded to it in his prepared remarks. So, The first thing we did was bring the markets closer to us and change the reporting lines, eliminating a layer within the previous international leadership team and essentially bring that business closer to the management table here in the US. The second step is we've made meaningful leadership changes across three really important markets, China, Japan, and Europe. That was about a year ago as well. What you're seeing now is a combination of those effects new strategies that have been developed and are being executed. And they're playing out differently in each market, right? You've got the changes we made in wholesaler and wholesaler inventory in Japan a year ago. We've got a new organization in Europe with a new strategy. And so I think there's a lot of really good things happening. If I had to peg it, I would say we're in the middle innings. We like what we've done over the last year to 18 months. but certainly you're bullish on continued upside across all of our international business. Before I go on, Rod, anything you would add to that?
Rod Little
Yeah, I think, Nick, Dan's captured it well. What I would double-click on, though, is the importance of leadership, having the right local leadership that's fit to win, capable to win locally. And we've done that now in the key markets, not only with the leaders themselves, but building out much more capable teams below them. I won't mention the market by name, but we have one market where we have an entirely new leadership team in place that's now been in place for over a year. We're starting to see the fruits of that. The final thing I'll mention relative to international is there's a big opportunity from here, and I think this is the back-end innings part of what's to come, to have our innovation be fit for purpose for more local Asian and European markets as opposed to exporting US ideas or innovating towards a global consumer that frankly doesn't exist. And so I think that's to come as we look towards 25 and six, we remain bullish on international.
Chris
Yeah, and then Nick, just to pick up the question on holding on the outlook, I think there's a couple of points I would make. You know, what we were really encouraged by in the quarter was the gross margin profile. Some of that is timing and phasing of what we have pulled forward into the quarter that we had phased for later in the year. That's just a reality. I think the general sentiment, though, is we're one quarter in. We haven't yet gotten into the sun season in the U.S., which we all know what that can mean for our business. And so we're just being prudent here about where we are in the year, what line of sight we have. We're confident. We feel really good with the start of the year and some of the underlying execution. But given the business that lies ahead of us, particularly in Sun, we obviously chose to hold the guide.
Nick
Makes total sense. Thanks, guys. I'll pass it on.
Chris Goff
Thank you, Nick. Operator, next question, please.
Operator
The next question is from Olivia Tong with Raymond James. Please go ahead.
Raymond James
Great. Thanks. Good morning. I wanted to understand a little bit about what came in better than expected on the expense line since since those, you know, you were pretty clear on the guide for this quarter sort of giving us caution around some of the inventory and some of the SG&A sort of being more in line with Q2 and Q3 of last year. So, you know, what sort of worked better than you thought? And, you know, as you think about you just sort of, you know, de facto gave us guide for Q2, which would suggest that in order to sort of stay in the range, Q3 and Q4 have to come in a little bit. Just, you know, talk a little bit about the puts and takes there, if you wouldn't mind. Thank you.
Chris
Yeah, good morning, Olivia. Sure. Look, I think the surprise, if you will, in Q1 was all in the margin profile. And it was obviously a good surprise, but it was the reflection of really good execution by the team on both the cost side of the ledger, so productivity worked harder for us and delivered more than we had expected, and on the revenue side, both in price and what we call SRGM. And I think there's sort of three factors that I would point to, and I'll kind of tick through them in order of magnitude, recognizing all three carry with them some phasing benefit that doesn't necessarily change the year but certainly was a benefit in the quarter. As I mentioned, the first item is productivity. The team did an excellent job on execution. They accelerated certain initiatives that we had phased later in our plans and really are executing at a high level. I think what was a bit of a surprise, which is timing in the quarter, is where global procurement was able to land certain global contracts, rebate programs, and settlements that we had planned for later in the year that hit us in the quarter in a good way, but really good execution. I think the second thing I would point to is mix. Anytime you see this level of growth in shave, right, we grew wet shave over 8% in the quarter, and particularly internationally in Japan where we had price increases attached to it, you got a mix benefit for the business. That is all entirely timing for us. And then the third piece is warehouse and distribution costs, which is a little bit of both. I think really good structural execution. We are seeing rates come down. We are seeing inflation easing. We also shipped heavy. We're very productive in our shipments in terms of full truckloads. So I put all that together. I would say to you the 200 basis point margin accretion in the quarter was more than we had profiled. And I would say roughly 75% of that is likely timing issues. 25% of that is structural. That was really what we saw in the quarter. On the expense lines, G&A, A&P, and otherwise, as we mentioned also in FX, lined up pretty much what we had expected.
Raymond James
Great, thanks. And just following up on advertising, obviously advertising plus or minus flies this quarter. The guide would suggest that there's more of an increase as the year progresses. Can you talk about the categories in particular that you would expect to see really ramp up with respect to the advertising?
Rod Little
Yeah, good morning, Livia. Rod here. We have the bulk of our innovation program for the year to come is in front of us. We talked about Billy Boddy launching actually yesterday and today as we launch into brick and mortar and online. with a new line of body products that we're very excited about. So that will be a net increase in investment in advertising and support behind that. We have what we believe is the number one innovation, the biggest and most disruptive innovation in sun care coming this year on Banana Boat 360 coverage mist. It's an alternative spray product for those that like sea sprays. They're typically propellant-driven, not great for the environment. This is a sustainable, non-propellant-driven spray. It's, we believe, a superior spray formulation. It's exclusive on banana boat. Beyond all the other innovation we have coming on SunCare, that's the number one thing that comes. You'll see us start to ramp up investment behind that as we come into the big spring and summer months. And the final piece is a carefree master brand replatforming where we have a major product upgrade coming on our carefree pads business, less plastic, more sustainable, more absorbent. We have a major simplification as part of that where we're collapsing the stay-free brand under carefree. So effectively going two brands into one with very strong retailer support and absolute clarity on the target for that new product. brand and positioning. It's moms. And we've got a very emotive campaign that we're going to put in place and spend against to drive that brand. So that's all still to come. And that's what I think you'll see coming in Q2 through the balance of these.
Operator
Great. Thank you. Best of luck.
Chris Goff
Thank you, Olivia. Operator, next question, please.
Operator
The next question is from Bill Chappell with Truist Securities. Please go ahead.
Bill Chappell
Thanks. Good morning. I guess two questions. Back on women's in the U.S., what's kind of the line of sight in the, I guess, beyond Walmart in terms of shelf space gains for this year? And do you think you can move, you know, have the similar type move for Billy in terms of total share? Are we narrowing the gap further? with where you are at Walmart, or, you know, is it less of a share gain than we saw last year?
Rod Little
Good morning, Bill. I think just relative to last year, less of a share gain, just given what's already in the base now. But as it relates to billing and distribution, there's some additional incremental distribution coming online this year around some of the regional players. All the big ones are covered. We're effectively national, but there's a little more fill-in to come. And then there's a couple of channels, a channel specifically that we've just turned on and online, and then there's always the club opportunity potentially out there for incremental distribution and coverage. And then we think the bigger play over time beyond shave is really realizing that it's the opportunity around a broader lifestyle brand and planning a much broader portfolio beyond Shea, which we think the brand has the right to do.
Bill Chappell
So is there a plan to step up marketing, advertising behind Billy this year now that you are kind of on a national platform or that's been building through all of last year anyways?
Rod Little
You will see an increased investment behind Billy this year that starts effectively now.
Bill Chappell
Got it. And then why don't I follow up on the Femcare question. Rod, I mean, I understand you have a new strategy and working on that, but STEM CARE seems to have had probably 10 different new strategies over the past 15, 20 years I've followed it. So, I mean, what gives you confidence that kind of volumes can stabilize again or actually grow?
Rod Little
Yeah, this is not a new strategy, Bill, with what's happening on CAREfree. This is part of the strategy put in place recently. A couple of years ago, with a new dedicated team in place to do that, we've had clarity of strategy, consistency, I think, of execution against that strategy, which was first just stabilize the business, take some cost out, stabilize the business. We've very much now moved into the phase of building better innovation, product performance focused around, you know, claims, better product formulation, better targeting of who we're talking to. So that's where we are in the phase of the journey. You're rightly pointing out, I think, Bill, a question or what could be a concern of what's really going on and can we be successful in femcare. Let me start by saying I completely believe we can be successful in femcare and we will be successful in femcare. and that we can maintain unit volume growth at least in line with category or ideally ahead of category over time, right? So you've had what's traditionally been a low single-digit growth category. If you hold share within that position, you're going to grow low single digits, all else being equal. We're coming on a period since the beginning of the pandemic where this category has been disrupted. If you go back to day one of the pandemic, that was one of the shelves that emptied out at the very beginning. We had supply disruptions. We, the category, not just us, the competitive set. And as recently as in the period we just lapped a year ago, we had competitors out of stock where we were benefiting from that position because we were in stock, which drove the double-digit growth in the period a year ago. We're lapping that today. So when you take year-ago growth with where we are today, we're actually at that low single-digit growth place on a two-year stack basis in the quarter just finished. The good news for us all, I think it'll be less messy going forward, is I think a lot of that is behind us in the category. And what we now cycle for our Q2, 3, and 4 is much more like-for-like, where consumption and our reported sales trends ought to match in a much closer way, not only for us, but also for competition as we go forward. I hope that helps.
Bill Chappell
That does. Thanks for the color.
Chris Goff
You bet. Thank you, Bill. Operator, next question, please.
Operator
The next question is from Chris Carey with Wells Fargo Securities. Please go ahead.
Chris Carey
Hi. Good morning. So just two questions, but I wanted to start with gross margin. So if I adjust the gross margin for the inventory impact this quarter, Obviously, the underlying run rate was quite a bit higher, closer to 46% gross margin. It sounds like, obviously, there was quite a bit of pull forward. But you're also implying, I guess, roughly 43% gross margins for the rest of the year. What's really driving that down sequentially? Is that all productivity? Do you expect mix to get worse? maybe thoughts on inflation. So just contextualizing, you know, why the underlying run rate sets down would be helpful. Then I would follow up.
Chris
Yeah. Hey, Chris, thanks for the question. Look, I think we have to put Q1 in proper context for what's structural versus what's timing, which I think I did in the previous question. But I think if you look at the elements that underpin the margin, Q1 is, we expect would likely be our strongest quarter for productivity savings, our strongest quarter for price realization. That's not to say that those won't drive quarters two through four, but the impact will be less. And so you'll start to see that scale down. Again, partly that is timing, but also partly that is just structural, the way productivity and pricing are profiled in. Equally, though, you will see inflation continue to ease, maybe at a bit of a slower rate over time. And so I think when you put all of that together, I would summarize it this way. I think we're super encouraged about the way the team executed and the gains that we saw in the quarter. We're hesitant to use Q1 as a proxy for the full year, given some of the timing dynamics and the way productivity and price will phase back half of the year. But we're certainly confident as we look at our full year outlook in terms of the margin profile that we laid out, which was essentially 100 basis points constant currency gain.
Chris Carey
Okay, that's helpful. Regarding organic sales growth for the year, there's a lot of moving pieces between strength in international markets, declines in North America this quarter. Obviously, wet shave had a very strong quarter. offset by, you know, sun care with kind of sun and skin being, you know, kind of maybe more neutral in the quarter. How do we frame the way that you're viewing the business for the rest of the year? I don't know if you can maybe offer some comments for expectations by segment, perhaps some expectations by – by international versus North America. I'm just conscious that you were talking about mixed impact and gross margin in the quarter, and maybe that changes go forward. So can you maybe just offer a bit more context on the complexion of the top line between international and North American segments for the rest of the year? That would be helpful. Thanks.
Rod Little
Yeah, Chris, good morning. It's a good question because there's a lot going on. but try to make it very, very simple. Last year, our international business outgrew our domestic U.S. business. Let's call it approximately double the rate. I would expect that to be about where we land this year, all else being equal in terms of if you look on a full-year basis, we have international growing ahead of our domestic U.S. business as we kind of look at it together. What you saw in quarter one on the U.S. business is by no means a proxy of the North America as we reported. As a proxy going forward, I would expect to see sequential improvement in our North American business throughout the balance of the year, largely because the innovation to come is domestically mostly here. We know we have better planogram outcomes around distribution outcomes in the balance of the year. And so I think as we look at how the year sets up, particularly as you normalize for FemCare, which was half of the Q1 delivery, you know, under delivery, as that normalizes, that kind of takes care of itself. So I think you'll see better North American performance in the balance of the year. I think you'll see the strength and international continue, albeit not at the absolute rate of growth we saw in the first quarter. Depending on weather, you ought to see a pretty resilient sun category. Shave, we think, continues to be on growth for us for the full year. And you'll see, again, I think, sequential improvement in both grooming and femcare as we cycle forward here through the balance of the year. Dan, I don't know if you'd clarify or add anything.
Chris
No, maybe to put some context to it, Chris, we still think that the 3% midpoint on organics is largely how it'll phase by quarter. So we don't necessarily anticipate a change there. And on the segment piece, we still anticipate, you know, sort of mid to high single-digit growth on the right to win portfolio and low single-digit growth on the right to play portfolio.
Chris Carey
Okay. That's helpful. Thank you.
Chris Goff
Thanks, Chris. Operator's question, please.
Operator
The next question is from Susan Anderson with Canaccord Genuity. Please go ahead.
Susan Anderson
Hi, good morning. Nice job on the quarter. I wanted to ask on the men's grooming. I think sales were slightly down, but I think you know that Bulldog was up. Maybe if you could give a little bit more color on the drivers there and what drove that growth, both domestic and international. Then also I'm curious if you have any new products coming out in the category for the year.
Chris
Good morning, Susan. Thank you for the question. Yeah, the grooming portfolio internationally had a very, very strong quarter in large part led by Bulldog, which grew about 18% year over year. The brand has now reached number two in the UK ahead of Nivea in the category, which is a significant accomplishment. And the team has worked very hard here. I would attribute it to three things. Continued distribution gains, which we had profiled in for the year. Interesting innovation. We've introduced the new advanced line for Bulldog, which is a more premium priced skin set of products for the brand, which has been very well received initially. And then innovation this year in the category, we're seeing it mostly in antiperspirant deodorant expansion, a bit into hair care. So the brand continues to really perform well in its home base and deliver results. some really exciting growth.
Susan Anderson
Okay, great. That's really helpful. And then also I wanted to ask just on transportation costs and the issues going on in the Red Sea, if you're expecting those or what your expectations are for transportation for this year. And then also just if you have any exposure to the issues there. Thanks.
Chris
Yeah. So the exposure is fairly limited. It would essentially be you know, shade product that moves between Europe and China. And what we've seen to date is very little disruption and very little complexity. We have built a bit of inventory. We have seen lead times expand a bit as we've had to go around the Cape as opposed to through the Red Sea. So far, it has been de minimis in terms of implications in both cost and complexity. Obviously, the teams have taken the right steps to plan for it, and we don't anticipate that there will be significant implications for the business this year, but obviously, like everyone else, we're monitoring the situation.
Susan Anderson
Okay, great. Thanks so much. Good luck the rest of the year.
Chris Goff
Thank you. Thanks, Susan. Operator, next question, please.
Operator
The next question is Peter Grom with UBS. Please go ahead.
Peter Grom
Thanks, Operator, and good morning, everyone. Hope you're doing well. So maybe one quick housekeeping question and then another one on gross margin. First, just kind of the pull forward you mentioned in Japan. Is there any way to kind of quantify that? I'm not sure if you mentioned that previously or not, but if you didn't, it would be helpful if you could share that. And then, you know, specifically on gross margin, you know, several times throughout this call, you mentioned a good chunk of this was timing related. But I would be curious whether, you know, the productivity performance you know, this quarter gives you greater confidence that there could be, you know, further savings to unlock as we look ahead. Thanks.
Rod Little
Yeah, hi, Peter. Good morning. Just the first part on Japan, I'll take it and flip it to Dan for the broader gross margin perspective. Look, we had a solid quarter in Japan driven by really three things. One was cycling a period in the year-ago period, so October, November, December, a year ago, so back to 22, that had relatively low shipments because of the way we had traditionally phased the business where we would have heavy promotion wholesale pushes in that August, September window. We're near the end of the year. It was just a historical practice that, frankly, I don't like, and I don't think the team likes. So we got out of that. And so think of it as we had an easy base to comp in the quarter one where we put up good growth. That was, you know, I would call it in the range of $5 to $10 million of an easy comp. But the bulk of the delivery then, the other two things are market growth. That market has returned to growth. It had a delayed recovery coming out of the pandemic, and we now have the market in the high single-digit growth territory. At least that's where it was in the quarter just finished. And we have incremental pricing and revenue management coming on top of that, where we've taken a couple rounds pricing in Japan and a market that hadn't seen much pricing activity over the last few years. So just catching up for inflation that's hit us in the P&L is now benefiting us. We had the cost in the P&L, but not the pricing help. We're now seeing that flow. And so I think we're optimistic on Japan for the future, but not nearly at the rate of what you are seeing, that we're now cycling like for like comps on how we're distributing and managing the business there.
Chris
Yeah, and on the margin piece, Peter, what I would say is, look, we're certainly encouraged by the results. And I think what we've demonstrated within our supply chain organization is we go pretty hard after productivity savings. And we've got in excess of 100 different initiatives ongoing at any point in time. And I think that the team will continue to lean in and accelerate where they can. So could there be upside there? I think there could be, would likely, more likely be on the cost side. I think on the revenue side, we've got a pretty good line of sight for what we phased in. All of our incremental pricing, which is mostly an international, has been sold in now. So there's no execution risk there, but I wouldn't anticipate upside. So I guess short answer to your question, I think could be. We're certainly not ready to call it yet, especially with some of the challenges we see in the macro environment. But if it were to come, it would be in productivity more likely than in revenue.
Chris Goff
Thank you. Thank you, Peter. Operator, next question, please.
Operator
At this time, there are no further questions. This concludes our question and answer session. I would like to turn the conference over to Rod Little, CEO, for any closing remarks.
Rod Little
Yeah, thank you, everyone. I appreciate the time today and the continued interest in the company, and we'll talk to you in three months with an update on Q2.
Operator
The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
Disclaimer